Categories: Wire Stories

Best�s Market Segment Report: AM Best Maintains Stable Outlook on South Korea�s Non-Life Segment

HONG KONG–(BUSINESS WIRE)–AM Best is maintaining its stable outlook on South Korea�s non-life insurance market, due to the segment’s record profitability as a result of significant improvement in automobile results and steady investment performance.

AM Best notes in its Best’s Market Segment Report, titled, “Market Segment Outlook: South Korea Non-Life Insurance,” that the non-life insurance industry’s net profits rose by 72% in 2021 to a record-high of KRW 3.7 trillion (USD 3.0 billion), thanks to markedly improved underwriting performance, especially in the automobile insurance line. “Although automobile claims are likely to rise in 2022 given the lifting of most COVID-19 restrictions, the larger premium base resulting from previous rate increases, as well as improving cost efficiency, will help the industry effectively manage its automobile profitability over the next 12 months,” said Chanyoung Lee, associate director, analytics, AM Best.

Overall, South Korea’s non-life industry registered solid premium growth of 4% in 2021, with gross premium written of KRW 89 trillion (USD 72.1 billion). The segment remains under pressure owing to elevated medical claims in the long-term insurance segment, driven by an increase in moral hazard and over-treatment by clinics and hospitals. However, the overall profitability of the long-term insurance line improved slightly, mainly because of a decline in the expense ratio due to subdued market competition.

Investment performance was largely stable in 2021. Despite a slight decline in investment yield, a continuously expanding asset base supported overall investment earnings, which increased by 4% from 2020.

AM Best expects South Korea’s non-life companies to see stable top-line expansion over the next 12 months, with growth supported by stable development in the long-term insurance line, driven by insurers’ continued efforts to increase sales of profitable health insurance and improve their persistency ratios.

To access the full copy of this market segment report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=320032.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2022 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Chanyoung Lee
Associate Director, Analytics
+852-2827-3404
chanyoung.lee@ambest.com

Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com

Jeff Mango
Managing Director,
Strategy & Communications
+1 908 439 2200, ext. 5204
jeffrey.mango@ambest.com

Alex

Recent Posts

Juicy Stakes Casino Move Quick With Speedy Sit & Go Spectacular

New slot tournament, Blackjack Quest and poker event here this month SYDNEY--(BUSINESS WIRE)--A new month…

7 hours ago

Teijin Automotive Technologies Celebrates Opening of Huntington, Indiana, Facility Expansion

AUBURN HILLS, Mich.--(BUSINESS WIRE)--#safety--Teijin Automotive Technologies held a ribbon cutting today to celebrate the opening…

9 hours ago

Capstone Copper Announces 2024 Annual General and Special Meeting Results

VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…

1 day ago

Indonesia International Remittance Market Growth and Future Opportunities 2024-2028: Rising Transaction Values and Volumes Characterize the Landscape – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…

1 day ago

KCAS Bio and Crux Biolabs Announce Global Spectral Flow Cytometry Alliance

KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…

2 days ago

Firstsource Acquires Quintessence

Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…

2 days ago